z-logo
Premium
Role of N‐end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine‐mTOR signaling pathway
Author(s) -
Kume Kanako,
Iizumi Yosuke,
Shimada Masashi,
Ito Yuki,
Kishi Tsutomu,
Yamaguchi Yuki,
Handa Hiroshi
Publication year - 2010
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/j.1365-2443.2010.01385.x
Subject(s) - leucine , ubiquitin ligase , biology , ubiquitin , biochemistry , phosphorylation , pi3k/akt/mtor pathway , p70 s6 kinase 1 , amino acid , microbiology and biotechnology , signal transduction , gene
Of 20 natural amino acids, leucine is particularly important for promoting cellular protein synthesis. The effect of leucine involves mammalian target of rapamycin (mTOR), a key protein kinase controlling cell growth. Leucine enhances mTOR‐mediated phosphorylation of S6K1 and 4E‐BP, thereby promoting protein synthesis. However, how the presence of leucine is sensed and transmitted to mTOR is poorly understood. Here, we show evidence that UBR1 and UBR2 might be cellular targets of leucine. UBR1 and UBR2 are E3 ubiquitin ligases that recognize the identity of N‐terminal residues and contribute to selective destabilization of target proteins according to the N‐end rule. Using leucine‐immobilized affinity beads, we identified UBR1 and UBR2 as leucine‐binding proteins from leucine‐responsive rat hepatoma H4IIE cells. Over‐expression of UBR1 or UBR2 resulted in a reduction in mTOR‐dependent S6K1 phosphorylation, whereas knockdown of UBR1 or UBR2 increased S6K1 phosphorylation in amino acid‐starved human 293T cells. We also found that leucine binds to the substrate‐recognition domain of UBR2 and inhibits degradation of N‐end rule substrates in vitro . These findings suggest that UBR1 and UBR2 are negative regulators of the leucine‐mTOR signaling pathway. Leucine might activate this pathway in part through inhibition of their ubiquitin ligase activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here